Form D · Pharmaceuticals
EyePoint Pharmaceuticals, Inc.
Watertown, MA · CIK 0001314102
Offering snapshot reported Jan 6, 2021 · SEC filing
- Reported sold
- $15.7M Offering amount: $15.7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 6, 2021 | Initial | $15,704,829 | No comparison | 1 | SEC filing |
| Apr 12, 2018 | Initial | $450,000 | No comparison | 1 | SEC filing |
| Apr 12, 2018 | Initial | $9,466,956 | No comparison | 3 | SEC filing |
| May 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 18, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 10, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-385343
Source: Form D, filed Jan 6, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Goran Ando | Director |
| James Barry | Director |
| Wendy Di Cicco | Director |
| Jay Duker | Director |
| Ronald W. Eastman | Director |
| George O. Elston | Executive |
| Douglas Godshall | Director |
| David R. Guyer, M.D. | Director |
| Scott Jones | Executive |
| John Landis, Ph.D., M.S. | Director |
| Ye Liu | Director |
| Nancy Lurker | Director, Executive |
| David Mazzo | Director |
| Dario Paggiarino | Executive |
| Dario Paggiarino, M.D. | Executive |
| Kristine Peterson | Director |
| Michael Rogers | Director |
| Leonard S. Ross | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
480 Pleasant Street Suite B300
Watertown, MA, 02472
Watertown, MA, 02472